North America is expected to maintain its leading position in the Chemotherapy Infusion Pumps Market throughout the forecast period, supported by a well-established healthcare infrastructure, high cancer treatment expenditure, advanced medical technology adoption, and the presence of major infusion-pump manufacturers. The region held the largest share of the market in 2023 and is expected to retain its dominance through 2031. Growing cancer incidence, increasing demand for precise drug delivery, and greater adoption of technologically advanced infusion systems are strengthening the regional outlook.

According to The Insight Partners, The Chemotherapy Infusion Pumps Market size is expected to reach US$ 17.45 Billion by 2031. The market is anticipated to register a CAGR of 7.3% during 2025-2031, compared with a market size of US$ 10.66 Billion in 2024. The report estimates a total addressable market of approximately US$ 99.90 Billion during 2025-2031, highlighting substantial commercial opportunities for manufacturers and technology providers. Rising cancer prevalence is a primary growth driver, while improved clinical outcomes and the growing geriatric population are further supporting demand. The increasing global cancer burden is expected to generate continued requirements for reliable and accurate chemotherapy administration systems.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPMD00002020

Chemotherapy Infusion Pumps Market Size, Share, Trends, Analysis, and Forecast by 2034

The published report provides a forecast through 2031; therefore, a 2034 market value is not stated in the source. The following points summarize the available market outlook without inventing a 2034 value.

• Market Size: The global market was valued at US$ 10.66 Billion in 2024 and is projected to reach US$ 17.45 Billion by 2031.
• Market Share: North America held the largest regional share in 2023 and is expected to maintain its leadership through the forecast period.
• Growth Rate: The market is projected to expand at a 7.3% CAGR from 2025 to 2031.
• Market Trends: Smart infusion pumps, wireless connectivity, customizable infusion rates, real-time monitoring, and advanced safety systems are key technology trends.
• Market Opportunities: Digital-driven droplet infusion technology, elastomeric pumps, and closed-loop systems are emerging as significant opportunity areas.
• End-User Trend: The home-care segment is expected to witness the highest growth, reflecting increasing interest in outpatient and home-based chemotherapy administration.
• Market Segmentation: The market is segmented by type into large-volume pumps, syringe pumps, elastomeric pumps, and others, and by end user into hospitals & clinics and home care.
• Forecast Outlook: Based on the published forecast, the market is positioned for sustained expansion through 2031, while opportunities beyond 2031 can be evaluated through customized forecasting.

Market Drivers and Trends

The rising prevalence of cancer is one of the strongest factors driving demand for chemotherapy infusion pumps. As the number of cancer patients increases globally, healthcare facilities require reliable systems for administering chemotherapy drugs at controlled rates. The growing geriatric population is another important driver because age-related cancers are becoming increasingly prevalent, creating additional demand for chemotherapy infrastructure.

Technological innovation is simultaneously transforming the product landscape. Modern infusion pumps are becoming more portable, accurate, connected, and user-friendly. Wireless communication enables healthcare professionals to monitor devices and treatment parameters more efficiently, while smart infusion pumps can incorporate algorithms and sensors to support accurate medication delivery. Customizable infusion rates and real-time monitoring capabilities are also improving the management of prolonged chemotherapy sessions.

Another important trend is the expansion of home-based cancer care. Elastomeric pumps can provide continuous medication delivery without requiring electricity or batteries, making them suitable for selected long-duration infusion therapies. Closed-loop systems with advanced alarm mechanisms can help identify issues such as air bubbles and occlusions, supporting safer administration. Digital-driven droplet infusion technology also presents an opportunity for highly precise medication delivery, including micro-dose administration.

Regional Analysis

North America: North America held the largest share in 2023 and is expected to remain dominant through 2031. High healthcare expenditure, advanced oncology infrastructure, technological adoption, and increasing cancer prevalence support regional growth.

Europe: Europe represents another important regional market, supported by established healthcare systems and increasing demand for advanced drug-delivery technologies. The report covers the UK, Germany, France, Russia, Italy, and the rest of Europe.

Asia-Pacific: Asia-Pacific offers significant growth potential due to expanding healthcare infrastructure, rising cancer awareness, improving access to treatment, and increasing adoption of advanced medical devices. The report covers China, India, Japan, Australia, and the rest of Asia-Pacific.

South and Central America: Brazil, Argentina, and other countries in the region are included in the market assessment, with growth influenced by improvements in healthcare services and cancer-treatment access.

Middle East and Africa: Saudi Arabia, the UAE, South Africa, and other countries are covered in the regional assessment. Improvements in healthcare infrastructure and growing demand for advanced treatment technologies support future opportunities.

Key Players in the Chemotherapy Infusion Pumps Market

The major companies profiled in the report include:

• BD
• ICU Medical, Inc.
• TERUMO CORPORATION
• B. Braun Melsungen AG
• HYH
• Smiths Group plc
• Baxter
• Fresenius Kabi AG
• MOOG, INC.
• Micrel Medical Devices SA

These companies are involved in developing and supplying infusion technologies and are assessed in the competitive landscape in terms of product offerings, strategic initiatives, and innovation developments.

About Us

The Insight Partners is an one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish